Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms
Nine de Graaf(Fondazione Poliambulanza Istituto Ospedaliero), Marc G. Besselink(Amsterdam Neuroscience), Johannes Berkhof(Amsterdam University Medical Centers), Patrick Maisonneuve(European Institute of Oncology), Daphne Droogh(Leiden University), J. Sven D. Mieog(Leiden University Medical Center), Luca Morelli(University of Pisa), Bas Groot Koerkamp, Clarissa Ferrari(Fondazione Poliambulanza Istituto Ospedaliero), Mahsoem Ali(Amsterdam Neuroscience), Jony van Hilst(OLVG), Martina Guerra(Fondazione Poliambulanza Istituto Ospedaliero), Olivier R. Busch(Amsterdam Neuroscience), Bergþór Björnsson(Linköping University), Ugo Boggi(University of Pisa), Misha Luyer(Radboud University Nijmegen), Anouk M. L. H. Emmen(Fondazione Poliambulanza Istituto Ospedaliero), Marco Ramera(Fondazione Poliambulanza Istituto Ospedaliero), Daan J. Lips(Medisch Spectrum Twente), Ignace H. J. T. de Hingh(Radboud University Nijmegen), C.L. Bruna(Amsterdam University Medical Centers), Freek Daams(Maine Farmland Trust), Giovanni Ferrari(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Sebastiaan Festen(OLVG), Mohammad Abu Hilal(University of Jordan), Roeland F. de Wilde(Karolinska University Hospital), I. Quintus Molenaar(University Medical Center Utrecht), Tobias Keck(Krankenhaus der Augustinerinnen)
Cited by 27
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k